- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 19/00 - Hybrid peptides
Patent holdings for IPC class C07K 19/00
Total number of patents in this class: 11593
10-year publication summary
|
592
|
787
|
822
|
909
|
1007
|
962
|
905
|
879
|
804
|
549
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20842 |
203 |
| The Trustees of the University of Pennsylvania | 4432 |
114 |
| The Board of Trustees of the Leland Stanford Junior University | 6697 |
79 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
79 |
| National Research Council of Canada | 1549 |
60 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
58 |
| The University of Tokyo | 4380 |
55 |
| The General Hospital Corporation | 4879 |
54 |
| Osaka University | 3261 |
54 |
| F. Hoffmann-La Roche AG | 7800 |
52 |
| Acceleron Pharma Inc. | 341 |
52 |
| JCR Pharmaceuticals Co., Ltd. | 226 |
50 |
| President and Fellows of Harvard College | 6110 |
47 |
| Nanjing Legend Biotech Co., Ltd. | 187 |
46 |
| Board of Regents, The University of Texas System | 6149 |
45 |
| The Johns Hopkins University | 5922 |
45 |
| Memorial Sloan-Kettering Cancer Center | 2056 |
45 |
| Ajinomoto Co., Inc. | 2282 |
39 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
38 |
| Novartis AG | 10175 |
37 |
| Other owners | 10341 |